2023年5月2日

关键外卖的预期上升的癌症病例预计刺激医疗高光谱影像市场的增长。市场增长是由类似的努力推动研究人员创建一个诊断疾病的方法。2022年,高光谱相机市场最大的市场份额。北美占最大的市场份额,主导市场。浏览完整的报告细节:https://www.fortunebusinessinsights.com/medical -高光谱成像-市场- 107460司机和限制:增加癌症病例增加市场轨迹增加癌症病例预计医疗高光谱影像市场的增长。检测肿瘤医学高光谱成像技术的主要应用之一,因为它提供了各种优点如非侵入性的性质,避免组织切片,并提供诊断签名不需要实时对比剂。根据世卫组织、癌症占将近1000万人死亡,在乳腺癌、肺癌和结肠癌是2020年的三大类别。增加研究探索医学应用有望推动市场的发展。然而,高成本和高数据存储的系统限制估计限制市场的增长。部分:高光谱相机决定,因为它是不可分割的一部分,系统组件的基础上,市场划分为高光谱相机及配件。 Hyperspectral camera segment had the highest share in 2022 as it is the main part of the system that captures the broad spectral range. The accessories segment is expected to grow substantially due to increasing technological advancements. Push Broom Segment to Govern due to Wide Adoption Based on modality, the market is categorized into push broom, snapshot, and others. Broom segment had the highest share in 2022 due to wide adoption and high spatial & spectral resolution offered by this modality. The snapshot segment is expected to grow significantly due to high data throughput and increased product launches. Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/medical-hyperspectral-imaging-market-107460 Report Coverage: The report provides a detailed analysis of the top segments and the latest trends in the market. It comprehensively discusses the driving and restraining factors and the impact of COVID-19 on the market. Additionally, it examines the regional developments and the strategies undertaken by the market's key players. Regional Insights: With Rising Technological Developments, North America to Lead Market Share North America is expected to govern the medical hyperspectral imaging market share due to rising technological developments. Strong presence of key market players and high cases of cancer in the U.S. contribute to the region's market growth. Europe is also expected to witness considerable market growth due to increasing public and private investments in R&D and technological advancements. Asia Pacific is anticipated to have a strong CAGR due to increasing awareness about the use of hyperspectral imaging in the healthcare industry and rising funding. Competitive Landscape: Imec Led the Market Share Owing to Increasing Number of Collaborations Imec, Specim, BaySpec, Inc., and Resonon Inc. were the leading medical hyperspectral imaging players in 2022. Imec was leading in the market in 2022 due to its strong portfolio of hyperspectral cameras. The company finds its presence in 96 countries and is involved in collaboration and partnership strategies to broaden its distribution network. In November 2020, Imec announced its collaboration with XIMEA for launching xiSpec2 hyperspectral camera. Specim also held a significant market share in 2022 due to increasing preference for the company’s hyperspectral cameras and accessories by healthcare professionals. List of Key Players Mentioned in the Report: Imec (Belgium) BaySpec, Inc. (U.S.) Market Analysis, Insights and Forecast – By Component Hyperspectral Cameras